KalVista Pharmaceuticals (KALV)
(Delayed Data from NSDQ)
$10.49 USD
-0.51 (-4.64%)
Updated Sep 20, 2024 03:59 PM ET
After-Market: $10.52 +0.03 (0.29%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 12/5/24 |
---|---|
Current Quarter | -0.95 |
EPS Last Quarter | -0.87 |
Last EPS Surprise | 8.42% |
ABR | 1.17 |
Earnings ESP
|
2.11% |
---|---|
Current Year | -3.35 |
Next Year | -1.55 |
EPS (TTM) | -3.53 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (10/2024) |
Next Qtr (1/2025) |
Current Year (4/2025) |
Next Year (4/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | 11.84M | 20.61M | 105.25M |
# of Estimates | NA | 1 | 2 | 4 |
High Estimate | NA | 11.84M | 35.51M | 149.08M |
Low Estimate | NA | 11.84M | 5.70M | 60.80M |
Year ago Sales | 0.00M | 0.00M | NA | 20.61M |
Year over Year Growth Est. | NA | NA | NA | 410.81% |
Earnings Estimates
Current Qtr (10/2024) |
Next Qtr (1/2025) |
Current Year (4/2025) |
Next Year (4/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.95 | -0.91 | -3.35 | -1.55 |
# of Estimates | 4 | 4 | 5 | 4 |
Most Recent Consensus | -0.92 | -0.95 | -3.72 | -2.08 |
High Estimate | -0.91 | -0.68 | -1.97 | -0.11 |
Low Estimate | -1.03 | -1.07 | -3.99 | -2.17 |
Year ago EPS | -0.80 | -0.84 | -3.44 | -3.35 |
Year over Year Growth Est. | -18.75% | -8.33% | 2.62% | 53.94% |
Agreement - Estimate Revisions
Current Qtr (10/2024) |
Next Qtr (1/2025) |
Current Year (4/2025) |
Next Year (4/2026) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 2 |
Up Last 60 Days | 1 | 1 | 1 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 2 | 3 | 0 |
Down Last 60 Days | 1 | 2 | 4 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (10/2024) |
Next Qtr (1/2025) |
Current Year (4/2025) |
Next Year (4/2026) |
|
---|---|---|---|---|
Current | -0.95 | -0.91 | -3.35 | -1.55 |
7 Days Ago | -0.95 | -0.91 | -3.35 | -1.55 |
30 Days Ago | -0.98 | -0.92 | -3.52 | -1.61 |
60 Days Ago | -0.96 | -0.86 | -3.38 | -1.50 |
90 Days Ago | -0.64 | -0.64 | -2.65 | -0.68 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (10/2024) |
Next Qtr (1/2025) |
Current Year (4/2025) |
Next Year (4/2026) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.93 | -0.85 | -3.19 | -1.45 |
Zacks Consensus Estimate | -0.95 | -0.91 | -3.35 | -1.55 |
Earnings ESP | 2.11% | 6.08% | 4.76% | 5.94% |
Surprise - Reported Earnings History
Quarter Ending (7/2024) |
Quarter Ending (4/2024) |
Quarter Ending (1/2024) |
Quarter Ending (10/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.87 | -1.02 | -0.84 | -0.80 | NA |
Estimate | -0.95 | -0.71 | -0.75 | -0.71 | NA |
Difference | 0.08 | -0.31 | -0.09 | -0.09 | -0.10 |
Surprise | 8.42% | -43.66% | -12.00% | -12.68% | -14.98% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more